<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study evaluates the incidence of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (APS) in systemic <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e> patients with anticardiolipin antibodies </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical presentations of systemic <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e> in patients with or without APS are examined as well </plain></SENT>
<SENT sid="2" pm="."><plain>The data from 242 consecutive patients suffering from <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (158 pts), systemic erythematoid <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> (53 pts), or systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (31 pts) are studied </plain></SENT>
<SENT sid="3" pm="."><plain>Enzyme immunoassay test for IgG-anticardiolipin antibodies was performed for <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>The IgG-anticardiolipin antibodies were found in 38 (15.7%) patients </plain></SENT>
<SENT sid="5" pm="."><plain>There were 16 (30.2%) patients in erythematoid <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> group, 9 (29%) patients in systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> group, and 13 (8.2%) patients in <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> group </plain></SENT>
<SENT sid="6" pm="."><plain>The diagnosis of secondary APS according to classificational criteria (1998) was confirmed in 14 (36.8%) from 38 seropositive patients: ten patients (62.5%) in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> group, 2 (22.2%) patients in systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> group, and 2 (15.4%) patients in <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> group were found as APS patients </plain></SENT>
<SENT sid="7" pm="."><plain>The majority of these patients were female (92.9%) </plain></SENT>
<SENT sid="8" pm="."><plain>These patients were younger as compared with systemic <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e> patients without APS (p=0.005) </plain></SENT>
<SENT sid="9" pm="."><plain>There was no significant difference found between APS patients and patients without APS in respect to neither duration of <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disease</z:e>, nor disease activity, nor course of the disease </plain></SENT>
<SENT sid="10" pm="."><plain>There were significantly more cases of fibrotic heart valves (p=0.028), and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (p=0.002), and <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> (p=0.058) in APS group </plain></SENT>
</text></document>